Article thumbnail

Depression Screening in Antepartum Females

By Michelle Burk

Abstract

Problem: Perinatal mood disorders, including depression, affects one in five pregnant or postpartum females. The American College of Obstetricians and Gynecologists (ACOG) and the US Preventative Task Force (USPTF) recommended screening for depression at least once during the antepartum and postpartum periods. The purpose of this quality improvement initiative was to introduce depression screening using the patient health questionnaire (PHQ) in antepartum women in a Midwestern private OB-GYN practice. Methods: An observational, descriptive, cohort design utilizing a retrospective record review was used to evaluate for PHQ depression screening. A convenience sample of antepartum patients at/or around 36-weeks gestation was studied. A Plan-do-study-act (PDSA) cycle was utilized. Results: There were 66 prenatal visits from January 2nd through March 20th, 2019. Of those, 54 patients (N=54) were screened with the PHQ-2 and four were screened further with the PHQ-9 (n=4). Most women screened negative for antepartum depression at 36-weeks gestation (n=50), but the PHQ-2 identified four at risk and in need of further evaluation with the PHQ-9 (χ2=39.19, df = 1, p Implications for Practice: Early identification of depression in pregnant females allowed for early medication management and counseling services. Further study is needed to determine if depression treatment during the antepartum period impacts the postpartum period

Topics: Antepartum, Depression, Screening, Maternal, Child Health and Neonatal Nursing, Medicine and Health Sciences, Nursing, Psychiatric and Mental Health Nursing
Publisher: IRL @ UMSL
Year: 2019
OAI identifier: oai:irl.umsl.edu:dissertation-1891

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.